Comparison of Kaltenborn Mobilization and Mobilization With Movement (MWM) in Wrist Hypomobility After Colle's Fracture
Launched by FOUNDATION UNIVERSITY ISLAMABAD · Jul 1, 2025
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of treatments to help improve wrist movement after a common wrist fracture called a Colles’ fracture. This fracture often causes stiffness, making it hard to move the wrist normally. The trial will compare Kaltenborn Mobilization, a hands-on technique where a therapist gently moves the wrist joint, with Mobilization With Movement (MWM), which combines therapist-guided movements with the patient’s own active motion. The goal is to see which method works better to reduce stiffness and improve wrist function.
People who might join this study are men and women between 40 and 70 years old who have had a Colles’ fracture treated with a plaster cast (not surgery) and are now experiencing stiffness in their wrist. Participants will be referred from an orthopedic doctor and should not have had any surgical procedures like pins or plates to fix the fracture. Those with other conditions affecting their nerves, rheumatoid arthritis, or other types of hand fractures will not be eligible. If you join, you can expect to receive one of these therapy techniques and have your wrist movement and comfort carefully monitored to understand which treatment helps best. This study is currently looking for participants who meet these criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both male and female participants (40-70 years old) Participants who will have diagnosed Colle's fracture and treated conservatively by plaster cast fixation and should referred from department of orthopedic surgery Patients group with post Colle's fractures stiffness
- Exclusion Criteria:
- • Patients having diagnosed Colle's fracture and treated with invasive procedure like K wiring, ORIF etc.
- • Patient with Neuromuscular injuries.(diagnosed)
- • Rheumatoid arthritis.
- • Patients with metacarpal fracture or compartment syndrome, non-union.(diagnosed)
About Foundation University Islamabad
Foundation University Islamabad (FUI) is a prominent educational institution dedicated to advancing research and innovation in various fields, including clinical sciences. With a commitment to excellence in education and healthcare, FUI fosters a collaborative environment that encourages multidisciplinary research initiatives. The university actively engages in clinical trials aimed at improving patient outcomes and contributing valuable insights to the medical community. Through its state-of-the-art facilities and a team of experienced professionals, Foundation University Islamabad strives to uphold the highest ethical standards in clinical research, ensuring the integrity and reliability of its findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, , Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported